about
Impaired B cell development and function in the absence of IkappaBNSIgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infectionCD93 is required for maintenance of antibody secretion and persistence of plasma cells in the bone marrow nicheActivation of B cells by non-canonical helper signalsThe longevity of Th2 humoral response induced by proteases natterins requires the participation of long-lasting innate-like B cells and plasma cells in spleenWaning and aging of cellular immunity to Bordetella pertussisIgE immunotherapy against cancerCationic lipid-formulated DNA vaccine against hepatitis B virus: immunogenicity of MIDGE-Th1 vectors encoding small and large surface antigen in comparison to a licensed protein vaccineAntigen presentation and the regulation of CD4 memory generation to influenza.Mcl-1 is essential for the survival of plasma cells.Invariant NKT cells sustain specific B cell responses and memory.Reduced pathology and improved behavioral performance in Alzheimer's disease mice vaccinated with HSV amplicons expressing amyloid-beta and interleukin-4.Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoproteinCatastrophic relapse of Evans syndrome five years after allogeneic BMT notwithstanding full donor chimerism. Terminal hemolytic-uremic syndrome.Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.Long-lived antibody and B Cell memory responses to the human malaria parasites, Plasmodium falciparum and Plasmodium vivaxThe BTB-ZF transcription factor Zbtb20 is driven by Irf4 to promote plasma cell differentiation and longevity.Polysaccharide-specific B cell responses to vaccination in humansMining human antibody repertoires.CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunity.Mechanisms of Autoantibody-Induced Pathology.Measuring changes in transmission of neglected tropical diseases, malaria, and enteric pathogens from quantitative antibody levels.Memory B cells and CD8⁺ lymphocytes do not control seasonal influenza A virus replication after homologous re-challenge of rhesus macaques.Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.Proteasome inhibition with bortezomib depletes plasma cells and specific autoantibody production in primary thymic cell cultures from early-onset myasthenia gravis patientsLiving on three time scales: the dynamics of plasma cell and antibody populations illustrated for hepatitis a virus.The immunosignature of canine lymphoma: characterization and diagnostic applicationEstimation of recent and long-term malaria transmission in a population by antibody testing to multiple Plasmodium falciparum antigens.Migration of antibody secreting cells towards CXCL12 depends on the isotype that forms the BCR.Rapid induction of autoantibodies during ARDS and septic shock.Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria.Deep Panning: steps towards probing the IgOme.The AP-1 transcription factor Fra1 inhibits follicular B cell differentiation into plasma cells.AllergoOncology: the role of IgE-mediated allergy in cancer.Quantitative assessment of the robustness of next-generation sequencing of antibody variable gene repertoires from immunized miceAntibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules.Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica.Viral immunology. Comprehensive serological profiling of human populations using a synthetic human viromeSpecific IgG response against Mycobacterium avium paratuberculosis in children and adults with Crohn's disease.Interferon-α induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB×NZW)F1 mice but not in BALB/c mice.
P2860
Q24625466-3758BFF4-E440-4EAF-AEC5-D08C5F487D83Q24631904-FB358140-05BF-4C1F-92E7-B97A671849A2Q24657562-6C30991A-1F1F-4F31-951D-3BBB21BCCE5DQ26866169-60315BD8-ADCA-49A2-AA01-BB144DCFB524Q27312551-A69E4CA8-555C-4752-B043-5E9EE274AD89Q28080731-C9FF9F3D-9CBD-4339-8685-D0166A58BCD1Q28081223-7F8E6320-E1CF-42C5-B4F9-568EA6A096AEQ28656316-2303AD2D-C1BB-4642-838D-98D2B4606DA3Q30389279-36660363-8710-45B6-AE5D-2AD65A299A03Q30412677-1E07280C-681D-4FDC-AE37-4913A145FEB3Q30479030-8D5AF728-D45D-433B-A2CD-1535B3247CB9Q30482492-5D8D6343-A575-4999-9461-D8A957F73E5CQ31055400-1A6DC8BF-BCA5-4F8E-B2C2-021B1F6398E2Q33373065-3235DC77-7BB2-4FB7-90F7-CF4FE6801F3FQ33412190-6A08CE8C-26B6-4126-BB9A-4C691F9ADC3CQ33533328-C3763D7E-CE9A-42CB-AD00-B761C2DFF1A9Q33569863-84CA6B3B-FF2A-457A-83DE-E218ADC19DE3Q33577958-8B14C4D1-4B7E-41A8-88CC-D60D21B605F7Q33588489-1FB9CAF9-91E0-4EBB-946D-5920E058F92CQ33603170-E4B03B76-A415-4CB2-BD1A-5930F46BA5A2Q33740580-699D4348-CF49-4B4A-ACE9-24765885EA84Q33752038-EA4874F8-5018-4A86-8A9A-1C3A801E18DEQ33957968-586CB7DD-4E51-4486-9569-B4F33A606CE9Q34052050-1A4CFCDA-7EAF-4D8C-953D-3B3EBE1B405DQ34085747-742A82F8-BAA8-47D9-97F5-9D54E5D1C61FQ34186939-540BDA4E-54F9-4F9E-B768-5D956BC1CF36Q34208766-323D395C-36BA-4141-9B30-DA70E6743CBBQ34209043-10DDBED7-33A6-4C6F-8CD4-640F5A3C105CQ34259851-6F6D67E9-B060-47E4-AEBF-082221EBC00CQ34267557-2FA2D5B3-D1C0-4C2D-9071-777B1CF8E3C8Q34303373-0DBF947E-3933-4B60-94CB-3D789A30F2C9Q34368932-0978EEF1-1109-487A-B8F9-2A84A6168757Q34375122-7106004B-A7F4-45F0-A92B-5819DFF82B8EQ34394208-4D54D39A-B9CB-4E3A-AEAA-8431F25E746DQ34517426-110B9E0B-1BF5-41E7-89F4-AD5DFF5DC78CQ34545880-E6A5FC04-55AB-441B-A5F7-273F67BA79A3Q34621516-51451E24-BFB0-4E37-BE08-AA47993CD56FQ34670348-68C70D20-7C2A-45BF-ACF7-4E014D439559Q34712776-F7C38DA0-B2EA-4A94-A806-4B668FDA8500Q34775978-1872CFF5-FF42-4F0F-9345-D5B786E86C98
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Maintenance of serum antibody levels.
@ast
Maintenance of serum antibody levels.
@en
type
label
Maintenance of serum antibody levels.
@ast
Maintenance of serum antibody levels.
@en
prefLabel
Maintenance of serum antibody levels.
@ast
Maintenance of serum antibody levels.
@en
P2093
P1476
Maintenance of serum antibody levels.
@en
P2093
Andreas Radbruch
Falk Hiepe
Rudolf A Manz
P304
P356
10.1146/ANNUREV.IMMUNOL.23.021704.115723
P577
2005-01-01T00:00:00Z